This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...

IONS reports better-than-expected first-quarter results. The company raises its sales guidance for 2025 by more than 20% on the back of two new licensing deals.

What to gift for Mother's Day? Though cards, chocolate, and flower arrangements are cherished traditions, they fall short in ...

Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization (CRDMO) with a next ?generation RNA precision manufacturing platform, today announced its participation ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

The process the immortal jellyfish uses to cheat death is like a form of cloning. If we can adapt it to the human body, it ...

TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based ...

BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...

Of the 30 companies on the list, 17 saw their stock prices decrease, 11 saw their share prices increase, and two had their stock prices remain flat.